Age: 18-75
Condition: Uncontrolled, Type 2 Diabetics currently using Semaglutide or Tirzepatide (Ozempic, Mounjaro or Zepbound) on the same dose for at least 3 months. A1c 7.5-10.5. Age 18-75 years old.
Study length: 6 months with 11 office visits.
Provided: Study related labs, physicals and testing as well as your Semaglutide or Tirzepatide (Ozempic, Mounjaro or Zepbound) along with an investigational diabetic medication. Compensation for all study visits.
Insurance is not needed.
Call 317-297-7999 x 3 or click the enroll today tab.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.